Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: Results of a prospective observational study - Université Clermont Auvergne Accéder directement au contenu
Article Dans Une Revue Bone Marrow Transplantation Année : 2021

Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: Results of a prospective observational study

Domaines

Hématologie

Dates et versions

hal-03737669 , version 1 (25-07-2022)

Identifiants

Citer

Johannes Schetelig, Jennifer Hoek, Stephan Stilgenbauer, Jan Moritz Middeke, Niels Smedegaard Andersen, et al.. Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: Results of a prospective observational study. Bone Marrow Transplantation, 2021, 56 (3), pp.692-695. ⟨10.1038/s41409-020-01013-y⟩. ⟨hal-03737669⟩
19 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More